Beyond recovery: long-term cardiovascular risks after severe COVID-19 requiring intensive care

• by Johanna Kämpe, Martin Jonson, Rebecka Rubenson Wahlin, Jacob Hollenberg, Per Svensson, Per Nordberg

• May 25, 2026

Cardiac magnetic resonance biomarkers for cardiovascular complications in diabetes: a systematic review and meta-analysis

• by Ning Li, Jitao Zhang, Yongyan Wang, Yugeng Li

• May 28, 2026

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min

Abnormal active myocardial relaxation by dipyridamole stress test in suspected early-stage heart failure with preserved ejection fraction: a retrospective exploratory analysis

• by Gabriella Locorotondo, Monica Filice, Francesca Augusta Gabrielli, Giacomo Moretti, Laura Manfredonia, Antonella Lombardo, Gaetano Antonio Lanza, Leonarda Galiuto

• May 28, 2026